1. Home
  2. CYD vs EYPT Comparison

CYD vs EYPT Comparison

Compare CYD & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo China Yuchai International Limited

CYD

China Yuchai International Limited

HOLD

Current Price

$35.73

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Logo EyePoint Pharmaceuticals Inc.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$16.11

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYD
EYPT
Founded
1951
1987
Country
Singapore
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
CYD
EYPT
Price
$35.73
$16.11
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$29.60
AVG Volume (30 Days)
161.6K
1.1M
Earning Date
08-08-2025
11-05-2025
Dividend Yield
1.48%
N/A
EPS Growth
40.10
N/A
EPS
1.66
N/A
Revenue
$3,159,401,156.00
$42,339,000.00
Revenue This Year
$41.12
N/A
Revenue Next Year
$6.93
N/A
P/E Ratio
$21.64
N/A
Revenue Growth
17.99
N/A
52 Week Low
$8.61
$3.91
52 Week High
$42.60
$19.11

Technical Indicators

Market Signals
Indicator
CYD
EYPT
Relative Strength Index (RSI) 48.45 59.80
Support Level $34.54 $15.97
Resistance Level $36.20 $19.11
Average True Range (ATR) 1.14 0.96
MACD 0.11 0.10
Stochastic Oscillator 55.00 44.91

Price Performance

Historical Comparison
CYD
EYPT

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: